Comparison of COVID-19 Vaccine Approvals at the US Food and Drug Administration, European Medicines Agency, and Health Canada
- PMID: 34170306
- PMCID: PMC8233699
- DOI: 10.1001/jamanetworkopen.2021.14531
Comparison of COVID-19 Vaccine Approvals at the US Food and Drug Administration, European Medicines Agency, and Health Canada
Abstract
This qualitative improvement study investigates COVID-19 vaccine approvals at 3 medicine regulatory agencies in the US, EU, and Canada, characterizing and contrasting regulatory review times, and analyzing the clinical evidence supporting authorization.
Conflict of interest statement
Similar articles
-
A Comparison of EMA and FDA Decisions for New Drug Marketing Applications 2014-2016: Concordance, Discordance, and Why.Clin Pharmacol Ther. 2020 Jan;107(1):195-202. doi: 10.1002/cpt.1565. Epub 2019 Aug 14. Clin Pharmacol Ther. 2020. PMID: 31306483 Free PMC article.
-
Characteristics of Recent Generic Drug Approvals by the US Food and Drug Administration.JAMA Netw Open. 2019 Oct 2;2(10):e1913029. doi: 10.1001/jamanetworkopen.2019.13029. JAMA Netw Open. 2019. PMID: 31603482 Free PMC article.
-
Despite criticism of the FDA review process, new cancer drugs reach patients sooner in the United States than in Europe.Health Aff (Millwood). 2011 Jul;30(7):1375-81. doi: 10.1377/hlthaff.2011.0231. Epub 2011 Jun 16. Health Aff (Millwood). 2011. PMID: 21680577
-
Characteristics of non-randomised studies using comparisons with external controls submitted for regulatory approval in the USA and Europe: a systematic review.BMJ Open. 2019 Feb 27;9(2):e024895. doi: 10.1136/bmjopen-2018-024895. BMJ Open. 2019. PMID: 30819708 Free PMC article.
-
Assessing tumor-related signs and symptoms to support cancer drug approval.J Biopharm Stat. 2004 Feb;14(1):5-21. doi: 10.1081/BIP-120028503. J Biopharm Stat. 2004. PMID: 15027497 Review.
Cited by
-
The effect of ChAdOx1 nCov-19 vaccine on arterial thrombosis development and platelet aggregation in female rats.Vaccine. 2022 Mar 18;40(13):1996-2002. doi: 10.1016/j.vaccine.2022.02.037. Epub 2022 Feb 17. Vaccine. 2022. PMID: 35183388 Free PMC article.
-
Efficacy and safety of interim oncology treatments introduced for solid cancers during the COVID-19 pandemic in England: a retrospective evidence-based analysis.Lancet Reg Health Eur. 2024 Sep 10;46:101062. doi: 10.1016/j.lanepe.2024.101062. eCollection 2024 Nov. Lancet Reg Health Eur. 2024. PMID: 39308982 Free PMC article.
-
A cross-sectional study of COVID-19 outbreak in Indian population.Ann Med Surg (Lond). 2022 Apr;76:103554. doi: 10.1016/j.amsu.2022.103554. Epub 2022 Apr 1. Ann Med Surg (Lond). 2022. PMID: 35382427 Free PMC article.
-
Current landscape of innovative drug development and regulatory support in China.Signal Transduct Target Ther. 2025 Jul 22;10(1):220. doi: 10.1038/s41392-025-02267-y. Signal Transduct Target Ther. 2025. PMID: 40691459 Free PMC article. Review.
-
"No Regrets" Purchasing in a pandemic: making the most of advance purchase agreements.Global Health. 2022 Jun 17;18(1):62. doi: 10.1186/s12992-022-00851-3. Global Health. 2022. PMID: 35715814 Free PMC article.
References
-
- US Food and Drug Administration. Development and licensure of vaccines to prevent COVID-19. June 2020. Accessed March 17, 2021. https://www.fda.gov/regulatory-information/search-fda-guidance-documents...
-
- Government of Canada. Vaccines and treatments for COVID-19: progress. Accessed April 21, 2021. https://www.canada.ca/en/public-health/services/diseases/2019-novel-coro...
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical